We have an outstanding group of keynotes from a who’s who in the international tech space. And they won’t just present and go home. At the presentations you’ll learn what they’re looking for and then they’ll be available for one-on-one meetings with you during the three days.
This is among the rarest of opportunities to get some facetime with the people who could help springboard your idea or product to market.
Dr Steven Griffiths - Masdar
Dr Steven Griffiths is the Executive Director of Institute Initiatives and Professor of Practice at the Masdar Institute of Science and Technology. At Masdar Institute Dr Griffiths has responsibility for developing large-scale, collaborative research programs that are typically part of broader strategic relationships with industry, government and academia. He also oversees the Institute’s Research Centers, Sponsored Programs and Technology Transfer Offices. Dr Griffiths additionally has an active role in multiple industry, research and innovation bodies outside of Masdar Institute, including the Emirates Solar Industry Association (ESIA) Board of Directors, Abu Dhabi Science, Technology and Innovation R&D Taskforce, and the Zayed Future Energy Prize Selection Committee. Dr Griffiths is Associate Editor and member of the Editorial Board of the international journal Energy Strategy Reviews. Prior to his role at Masdar Institute, Dr Griffiths was the Executive Director of the MIT Technology and Development Program’s MIT/Abu Dhabi Program and the founding Executive Vice President of Light Pharma Inc. In these roles he worked in the United States, India and, the Middle East leading the development and implementation of technical and strategic relationships. His interests and expertise are process design, technology strategy and financial analysis in the areas of information technology, biotechnology, and advanced energy technologies. Dr Griffiths holds a PhD in Chemical Engineering from the Massachusetts Institute of Technology (MIT) and an MBA from the MIT Sloan School of Management.
Mr Martin Bloom - ReneSola
Mr Martin Bloom, Board Chairman at ReneSola, Board Director with Intelligent Energy, CEO at Emblem Ventures, and a professional investor in high technology companies. Martin is a unique businessman who will discuss business building as a creative endeavor, with a focus on investment in and scale up of high growth technology companies. Martin’s skill is in deconstructing business models to make them scalable by removing barriers to growth. He builds businesses, directly and indirectly, using a combination of almost 40 years business acumen and artistic vision. Martin has used his unique talents to build scalable high growth businesses in the US, Europe, and China, where he spends over a quarter of his time. Martin sees China as critical for the high growth prospects of Western companies.
Martin became involved with China in 2001, and was appointed UK Chairman of the China-UK Venture Capital Joint Working Group, launched by Gordon Brown during his official visit to China in February 2005, to foster collaboration between the venture capital and private equity industries in both countries. As Board Chairman, Martin assisted Chinese solar wafer manufacturer ReneSola to list first on the London AIM and then on the New York Stock Exchange (NYSE: SOL). Annual revenues grew from $5 million to $1.2 billion within five years. His recent commitments include joining the Board of British fuel cell company Intelligent Energy.
Since 1997, Martin has been actively building businesses through a combination of mentoring entrepreneurs in the UK, US and China, investing in international high growth companies, and/or joining company boards to design and drive forward unique business models and raise financing for these companies, including through public listings.
Dr Waguih Ishak - Corning Inc
Dr Waguih Ishak, Division Vice President, Corning, Inc. Corning is the world leader in specialty glass and ceramics. Drawing on more than 150 years of materials science and process engineering knowledge, Corning creates and makes keystone components that enable high-technology systems for consumer electronics, mobile emissions control, telecommunications and life sciences. Dr Ishak will present materials, micro and nano structure technologies for the digital society of the 21st Century.
Dr Ishak joined Corning in 2007 as the Division VP and Director of the Corning West Technology Center. Waguih manages a team of scientists to develop applications for Corning's glass and fiber technologies and to conduct state-of-the-art research in the areas of microstructures and nanotechnology. Prior to Corning, he had 30 years of R&D technical and management positions and executive positions at Avago, Agilent Labs, and Hewlett-Packard Laboratories.
Dr Alexei A. Andreev - Harris & Harris
Alexei A. Andreev is Executive Vice President & Managing Director of Harris & Harris. Harris & Harris Group has been investing in companies with proprietary technology since 1983. For most of their history, they were a very small firm that invested in and helped develop early stage businesses, particularly ones founded on proprietary intellectual property. They have grown significantly and are connected to many large corporations strategic investments. Dr Andreev is an expert on nanotechnology and material science investment opportunities. Dr Andreev was previously with Draper Fisher Jurvetson and TLcom Capital Partners, a London-based venture capital fund backed by Morgan Stanley, prior to that he was with Renaissance Capital Group/Sputnik Funds in Russia.
Travis Earles - Lockheed Martin
Travis Earles, Executive for Lockheed Martin Corporate Engineering & Technology, leading and coordinating Advanced Materials and Nanotechnology Initiatives across the corporation. Lockheed Martin is a global leader in security products worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. Prior to joining Lockheed Martin, Travis served as Assistant Director for Nanotechnology in the White House Office of Science and Technology Policy, where he joined in 2007. He co-chaired the National Science and Technology Council Subcommittee for Nanoscale Science, Engineering and Technology (NSET), overseeing interagency coordination of the $1.8 billion National Nanotechnology Initiative and reaching out to the science and technology community across academia, government, and industry to foster resp onsible development of nanotechnology. At the National Cancer Institute prior to serving at the White House, Earles played a central role planning and implementing the five-year, $144 million Alliance for Nanotechnology in Cancer launched in 2005 (and extended in 2010), which has generated nearly a dozen technology platforms in clinical trials for diagnostic and/or therapeutic applications.
Dr Harrison Dillon - Solazyme
Dr Harrison Dillon is the President, Chief Technology Officer, and co-founder of Solazyme. Solazyme, Inc. is an industrial biotechnology company producing renewable oils and bioproducts using microalgae. Founded in 2003 and headquartered in South San Francisco, Solazyme's unique technology allows algae to produce oil and biomaterials in standard fermentation facilities quickly, efficiently and at large scale. These oils and biomaterials are tailored not only for biofuel production, but also as replacements for fossil petroleum and plant oils in a diverse range of products running from clean fuels and chemicals to cosmetics and foods.
Dr Dillon is a pioneer and thought leader in the renewables field. Along with Jonathan Wolfson he started Solazyme in his Palo Alto garage at a time when few in Silicon Valley had heard of the concept of biofuels. Taking on a variety of roles through the evolution of the company from garage startup to a sector leader, Dr Dillon has guided the company’s renewable oil production technology development through numerous phases. In 2010 Dr Dillon was the highest ranked scientist in Biofuels Digest’s “Top 100 People to Know in Bioenergy.”He is an inventor on over 30 of Solazyme’s patents and patent applications.
Dr Sergio Kapusta - Royal Dutch Shell
Sergio Kapusta currently is Chief Scientist for Royal Dutch Shell and General Manager of Physics & Materials Research at Shell International E&P Inc, based in Houston, where he oversees research and development in the areas of materials, corrosion, asset integrity, reliability, energy efficiency, and physical methods of analysis. Shell is one of the leading innovative companies testing, developing and piloting micro and nano technologies for applications in exploration and efficient recovery, as well as the use of nano technology for new materials and catalysts for production, micro systems for global seismic sensors and inertial products for directional drilling.
Sergio has been employed with Shell Oil Company for more than 25 years. During this time, he has held positions of increasing responsibility in Research, Engineering and Operations, in all major segments of the oil and gas business: production, transportation, and processing. His areas of expertise include materials, corrosion, asset integrity, reliability, and energy efficiency. He has also consulted with major oil and gas companies all over the world in topics of corrosion, risk assessment, and materials selection.
Dr John Parmentola - General Atomics
Dr John Parmentola, Senior Vice President Energy and Advanced Concepts at General Atomics. General Atomics is a San Diego-based innovation firm with more than a half-century of successful solutions for energy, environmental and defense challenges. GA specializes in performing innovative R&D and transforming conceptual results into practical systems – groundbreaking technologies ranging from the MagLev train to the Triga reactor to the Predator drone.
Dr Parmentola has built a career as a pioneer,entrepreneur and innovator, with broad experience in the private sector, academia and in high-level positions within the federal government and US defense community. John leads the California-based technology company’s Energy and Advanced Concepts Group work in nuclear energy R&D, biofuels, defense, IT, electromagnetic technologies and oversight of DIII-D National Fusion Facility, the largest in the US.
The MIT-trained physicist served as Director for Research and Laboratory Management for the US Army, overseeing a $1-billion combined budget for basic and applied research, environmental quality and manufacturing technologies, small business innovative research and high-performance computing programs. In addition, Dr Parmentola served as science and technology advisor to the chief financial officer of the US Department of Energy, providing technical, budgetary and programmatic advice to DOE leaders for more than $7 billion in science and technology investments.
Chris Hartshorn - Lux Research
Chris Hartshorn is the Chief Research Officer at Lux Research. Chris leads Lux Research’s teams of industry analysts and consultants in providing on-going emerging technology intelligence and strategic advice for the world’s leading technology companies. He is a sought-after speaker, delivering keynote speeches focused on emerging technology opportunities and challenges, and counter-intuitive insights in executive panels and discussions. Chris draws on extensive experience advising clients on a range of emerging technology areas including green buildings, water efficiency, energy storage, biofuels, advanced materials and photovoltaics and waste. Having previously directed Lux Research’s consulting practice, Chris has led numerous corporate, investor and start-up projects, providing navigation and recommendations on the emerging technologies and adoption landscapes critical to future business growth. Prior to joining Lux Research, Chris worked for General Electric, managing global technology programs as well as in product development within its materials businesses. Earlier, he held positions as a postdoctoral fellow at the University of North Carolina and as Senior Scientist contracted to the U.S. Naval Research Laboratory’s Center for Biomolecular Science and Engineering. Chris received his Ph.D. in chemistry from the University of Canterbury and is the author of over 25 scientific articles and reviews, and co-inventor of numerous patents in the field of chemical and materials development.
Stephen Graham - Maple Leaf Foods
Stephen Graham is Chief Marketing Officer at Maple Leaf Foods Inc. Mr. Graham is responsible for providing executive leadership to all marketing and product development initiatives across Maple Leaf Foods businesses. Other areas of responsibility include Marketing Services, Media Services, Innovation, Digital, Consumer Affairs, Mapleleaf.com and the ThinkFOOD! Centre. Maple Leaf Foods Inc. is a leading food processing company, headquartered in Toronto, Canada. The Company employs approximately 19,500 people at its operations across Canada and in the United States, the United Kingdom, and Asia. The Company had sales of $4.9 billion in 2011. Mr. Graham has over 25 years of senior leadership experience in marketing and has consistently generated exceptional results in tier one companies. Mr. Graham began his career at Procter & Gamble and has since overseen marketing for some of the world’s and Canada’s leading companies and brands including, Coca-Cola, AT&T, CIBC and Rogers Communications. While leading marketing for AT&T in the U.S. he was ranked #1 by Advertising Age in their Power 50 selection of top global marketers. Most recently, under Mr. Graham’s marketing leadership, Marketing Magazine selected Maple Leaf Foods as Canada’s 2011 Marketer of the Year.
Dr Claus Schmidt - Robert Bosch
Dr Claus Schmidt, Managing Director at Robert Bosch Venture Capital, is located in the Stuttgart office and responsible for the technical strategies and decisions at RBVC. Apart from serving as a partner in RBVC he maintains the contacts to the Bosch management organisation. After 24 years in different operational jobs with IBM, DEC and including 16 years with Bosch he joined RBVC as one of the founding managing directors at the end of 2007. Claus gained insight into various markets, such as disk drives, display technology, automotive electronics and semiconductors and into different management challenges starting from research, development, quality and reliability engineering to purchasing, P&L repsonsibility and general management. He got his PhD from the University of Stuttgart after staying at the Max-Planck Institute for Metal Physics in Stuttgart.
Dr Shuichiro Ogawa - Asahi Kasei
Dr Shuichiro Ogawa is a general manager, the R&D group of Advanced Energy Materials Development Center, Asahi Kasei Corporation. Asahi Kasei Group has a long tradition of innovation in a wide range of industries including chemicals, fibers, electronics, construction materials, pharma, and homes. Asahi Kasei Group is a global leader with over 25,000 employees and offices worldwide. Dr Ogawa responsibilities include development and commercialization of new functional materials for solar energy applications. He is an expert on nanotechnology and material science and at The University of Texas at Austin, he studied photoelectrochemistry of semiconductor nanoparticles. Dr Ogawa has held management roles including director of the London office of Asahi Kasei Corporation and external technology manager for nearly ten years building and managing R&D collaborations and licenses with USA, Europe and Japanese organizations.
Dr Helen Greiner - CyPhy Works
Dr Helen Greiner is Founder and CEO of CyPhy Works and co-founder of iRobot (NASDAQ:IRBT), a Massachusetts Institute of Technology spin-off and global leader of practical robots including the Roomba™ Vacuuming Robot and the PackBot™ and SUGV Military Robots. A robot industry pioneer with more than two decades of experience, Helen’s helped to enhance public acceptance of robots as one of today’s most important emerging technologies. Her visionary contributions in technology innovation and business leadership have been recognized with numerous professional awards. She’s been named one of America’s Best Leaders by the Kennedy School at Harvard University in conjunction with U.S. News & World Report and has been honored with the Pioneer Award from the Association for Unmanned Vehicle Systems International (AUVSI). Helen’s also been named New England Entrepreneur of the Year by Ernst and Young with iRobot Co-Founder Colin Angle.
Dr Darrel Untereker - Medtronic
Dr Darrel Untereker is currently the Vice President of Corporate Research and Technology, and a Senior Technical Fellow with Medtronic, Inc. Medtronic is the global leader in medical technology- alleviating pain, restoring health, and extending life for people with chronic conditions around the world. Medtronic develops and manufactures a wide range of products and therapies with emphasis on providing a complete continuum of care to diagnose, prevent and monitor chronic conditions. Darrel has won many internal Medtronic awards and is a Fellow in both the Electrochemical Society and the American Institute for Medical and Biological Engineering. He is a 2006 winner of the Charles W Britzius Distinguished Engineer Award for lifetime achievement in and service to the profession of engineering. Darrel is a frequent reviewer for many technical journals and also spends a large amount of time as a mentor and volunteering for organizations like the American Society for Quality and First Robotics. He has over 65 publications and over 20 patents including the Medtronic Star of Excellence, the Medtronic Outstanding Initiative Award, as well as being selected to the Bakken Society, which is the highest technical honor in Medtronic (named for Earl Bakken, the founder of Medtronic). Darrel received his undergraduate degree from the University of Minnesota and a doctorate from the University of New York at Buffalo, both in chemistry. Dr Untereker joined Medtronic, Inc. in Minneapolis, MN in 1976 and has held several technical and managerial positions over the years involving power sources, materials science and biomedical engineering of implantable medical devices.